[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENTS

1              Introduction

1.1          Market Definition

1.2          Market Scope

2              Research Methodology

2.1          Primary Research

2.2          Research Methodology

2.3          Assumptions & Exclusions

2.4          Secondary Data Sources

3              Market Overview

3.1          Report Segmentation & Scope

3.2          Value Chain Analysis: Sleeping Pills Market

3.3          Key Market Trends

3.3.1      Drivers

3.3.2      Restraints

3.3.3      Opportunities

3.4          Porter’s Five Forces Analysis

3.4.1      Bargaining Power of Suppliers

3.4.2      Bargaining Power of Buyers

3.4.3      Threat of Substitution

3.4.4      Threat of New Entrants

3.4.5      Competitive Rivalry

3.5          Market Share Analysis

4              By Product Type

4.1          Introduction

4.1.1      Market Size & Forecast (Value)

4.2          Benzodiazepines

              4.3          Non-Benzodiazepines

5.            By Uses

5.1          Introduction

5.1.1      Market Size & Forecast (Value)

5.2          Short-Term Use

5.3          Long-Term Use

6              By Regional Overview

6.1          Introduction

6.1.1      Market Size & Forecast (Value)

6.2          America

6.2.1      North America

6.2.1.1   U.S.

6.2.1.1.1               By Products Type

6.2.1.1.2               By End Users

6.2.1.2   Canada

6.2.1.2.1               By Products Type

6.2.1.2.2               By End Users

6.2.1.3   Mexico

6.2.1.3.1               By Products Type

6.2.1.3.2              By End Users

6.2.2      South America  

6.2.2.1                   By Products Type

6.2.2.2                  By End Users

6.3          Europe

6.3.1      Market Size & Forecast (Value)

6.3.2      Western Europe

6.3.2.1         Germany      

6.3.2.1.1               By Products Type

8.3.2.1.2               By End Users

6.3.2.2         France

6.3.2.2.1               By Products Type

6.3.2.2.2               By End Users

6.3.2.3         U.K  

6.3.2.3.1               By Products Type

6.3.2.3.2              By End Users

6.3.2.4         Italy

6.3.2.4.1               By Products Type

6.3.2.4.2               By End Users

6.3.2.5         Spain              

6.3.2.5.1               By Products Type

6.3.2.5.2               By End Users

6.3.2.6         Rest of Western Europe         

6.3.2.6.1               By Products Type

6.3.2.6.2               By End Users

6.3.3      Eastern Europe

6.4          Asia Pacific

6.4.1      Market Size & Forecast (Value)

6.4.2      China

6.4.2.1         By Products Type

6.4.2.2        By End Users

6.4.3      India

6.4.3.1         By Products Type

6.4.3.2        By End Users

6.4.4      Japan

6.4.4.1         By Products Type

6.4.4.2         By End Users

6.4.5      South Korea

6.4.5.1         By Products Type

6.4.5.2        By End Users

6.4.6      Australia

6.4.6.1 By Products Type

6.4.6.2 By End Users

6.4.         Rest of Asia-Pacific

6.4.7.1 By Products Type

6.4.6.2 By End Users

6.5          Middle East & Africa

6.5.1      Market Size & Forecast (Value)

6.5.2      The Middle East

6.5.2.1         Saudi Arab

6.5.2.1.1               By Products Type

6.5.2.1.2               By End Users

6.5.2.2         UAE

6.5.2.2.1               By Products Type

6.5.2.2.2               By End Users

6.5.2.3         Qatar

6.5.2.3.1               By Products Type

6.5.2.3.2               By End Users

6.5.2.4         Rest of Middle East

6.5.2.4.1               By Products Type

6.5.2.4 2               By End Users

6.6          Africa

6.6.1            By Products Type

6.6.2            By End Users

7.            Company Profile

7.1          Merck & Co., Inc.

7.1.1      Company Overview

7.1.2      Financial Performance

7.1.3      Recent Developments

7.1.4      Product Type

7.2          GlaxoSmithKline plc.

7.2.1      Company Overview

7.2.2      Financial Performance

7.2.3      Recent Developments

7.2.4      Product Type

7.3          CareFusion

7.3.1      Company Overview

7.3.2      Financial Performance

7.3.3      Recent Developments

7.3.4      Product Type

7.4          Apotex Inc.

7.4.1      Company Overview

7.4.2      Financial Performance

7.4.3      Recent Developments

7.4.4      Product Type

7.5          Sanofi

7.5.1      Company Overview

7.5.2      Financial Performance

7.5.3      Recent Developments

7.5.4      Product Type

7.6          Takeda Pharmaceutical Company

7.6.1      Company Overview

7.6.2      Financial Performance

7.6.3      Recent Developments

7.6.4      Product Type

7.7          Pfizer Inc.

7.7.1      Company Overview

7.7.2      Financial Performance

7.7.3      Recent Developments

7.7.4      Product Type

7.7          Eli Lilly and Company

7.8.1      Company Overview

7.8.2      Financial Performance

7.8.3      Recent Developments

7.8.4      Product Type

              7.9           Dr. Reddy’s Laboratories Ltd

7.9.1      Company Overview

7.9.2      Financial Performance

7.9.3      Recent Developments

7.9.4      Product Type



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports